These studies strongly suggest that SHS increases the risk of developing MCI and dementia by perturbing brain metabolism (i.e., insulin signaling, oxidative stress) and the accumulation of neuropathological proteins (i.e., tau, amyloid). This evidence concerns the gene MAPT and dementia.